申请人:TAIHO PHARMACEUTICAL COMPANY, LIMITED
公开号:EP0373226A1
公开(公告)日:1990-06-20
Carbamoyl-2-pyrrolidinone compounds quite useful as an agent for treating senile dementia, or improving brain functions, or activating and protecting brain metabolism, which are represented by formula (2) (wherein R1 represents a hydrogen atom, a hydroxy group or an optionally hydroxy-substituted lower alkyl group, R3 represents a phenyl, tetrahydronaphthyl, pyridyl or thiazolyl group optionally substituted by a lower alkoxy group, a lower alkylamino group, a halogen atom or a halogenomethyl group) are disclosed. Also disclosed are novel carbamoyl-2-pyrrolidinone compounds represented by general formula (1), wherein R1 represents a hydrogen atom, a hydroxy group or an optionally hydroxy-substituted lower alkyl group, and R2 represents a phenyl, tetrahydronaphthyl, pyridyl or thiazolyl group optionally having a methoxy group or a lower alkylamino group as a substituent, provided that R2 does not represents an unsubstituted phenyl group when R1 represents a hydrogen atom or an unsubstituted lower alkyl group.
本发明公开了由式(2)代表的氨基甲酰基-2-吡咯烷酮化合物(其中 R1 代表氢原子、羟基或任选被羟基取代的低级烷基,R3 代表任选被低级烷氧基、低级烷氨基、卤原子或卤代甲基取代的苯基、四氢萘基、吡啶基或噻唑基)。还公开了通式(1)代表的新型氨基甲酰基-2-吡咯烷酮化合物,其中 R1 代表氢原子、羟基或任选被羟基取代的低级烷基,R2 代表任选被甲氧基或低级烷基氨基取代的苯基、四氢萘基、吡啶基或噻唑基,条件是当 R1 代表氢原子或未取代的低级烷基时,R2 不代表未取代的苯基。